Farshad Guirakhoo
0000-0003-0124-013X
GeoVax, Inc.
34 papers found
Refreshing results…
Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: Infant mice provide an accurate surrogate for the test in monkeys
Cutaneous Delivery of a Live, Attenuated Chimeric Flavivirus Vaccines against Japanese Encephalitis (ChimeriVaxTM-JE) in Non-Human Primates
Recombination and flavivirus vaccines: a commentary
Replication of chimeric yellow fever virus-Dengue serotype 1-4 virus vaccine strains in dendritic and hepatic cells
Construction of Yellow Fever/St. Louis Encephalitis Chimeric Virus and the Use of Chimeras as a Diagnostic Tool
Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine
Analysis of the Replication Kinetics of the Chimerivax™-Den 1, 2, 3, 4 Tetravalent Virus Mixture in Aedes Aegypti by Real-Time Reverse Transcriptase–polymerase Chain Reaction
High Fidelity of Yellow Fever Virus RNA Polymerase
Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax-JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen
Traditional and novel approaches to flavivirus vaccines
Growth characteristics of ChimeriVax-DEN2 vaccine virus in Aedes aegypti and Aedes albopictus mosquitoes
Single Mutation in the Flavivirus Envelope Protein Hinge Region Increases Neurovirulence for Mice and Monkeys but Decreases Viscerotropism for Monkeys: Relevance to Development and Safety Testing of Live, Attenuated Vaccines
Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing
Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections
Missing publications? Search for publications with a matching author name.